SCHEMBL28057673

SCHEMBL28057673

Cc1csc(N)c1-c1ccccc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.46
BCAT2 O15382 1/20 0.46
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
ALDH1A1 P00352 5/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 1/20 0.40
BRD4 O60885 1/20 0.39
HPGD P15428 4/20 0.38
KDM4E B2RXH2 3/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GAA P10253 1/20 0.38
CSNK1A1 P48729 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
GRK6 P43250 1/20 0.38
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156837 0.83 MYC (0.45) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL28826828 0.79 POLB (0.51) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL28134011 0.78 BCAT2 (0.46) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL4138458 0.78 MYC (0.72) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL27679725 0.74 BCAT2 (0.45) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL28522305 0.73 MYC (0.56) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL1788703 0.72 BCAT2 (0.59) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL21590178 0.71 MYC (0.57) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL30514077 0.71 BCAT2 (0.74) BCAT2KEAP1NFE2L2ALDH1A1MAPT
SCHEMBL210767 0.71 BCAT2 (0.74) BCAT2KEAP1NFE2L2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 CN disclosed
CN-105531268-A Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV 2016-04-27 CN disclosed